Nyxoah S.A. (NYXH)
$1.28-2.29%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $51M
- Short % float
- 1.36%
- Days to cover
- 1.5
- SI change
- +19.7%
- 1W
- -10.49%
- 1M
- -20.00%
- vs SPY 1W
- -10.35%
- vs SPY 1M
- -22.51%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
NO COVERAGECompany news
FAQ
- What is LOPJLB’s current signal on NYXH?
- LOPJLB’s latest quantitative signal on Nyxoah S.A. (NYXH) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NYXH in?
- Nyxoah S.A. (NYXH) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Nyxoah S.A. (NYXH) do?
- Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The companyâs lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, B…